Targeted agents in patients with progressive glioblastoma—A systematic meta‐analysis of randomized clinical trials

URN to cite this document:: urn:nbn:de:bvb:355-epub-586172
DOI to cite this document:: 10.5283/epub.58617

Ippen, Franziska Maria

; Scherm, Angelika ; Kessler, Tobias ; Hau, Peter

; Agkatsev, Sarina ; Baurecht, Hansjörg

; Wick, Wolfgang ; Knüttel, Helge

; Leitzmann, Michael F.

; Seliger‐Behme, Corinna

License: Creative Commons Attribution 4.0
PDF - Published Version
(674kB)

Date of publication of this fulltext: 16 Jul 2024 05:38

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background Glioblastoma (GB) is the most common malignant primary brain tumor in adults and is associated with a poor prognosis. Current treatment guidelines outline the standard of care for patients with newly diagnosed GB; however, there is currently no well-established consensus for the treatment of progressive GB. With this systematic meta-analysis of recently published randomized controlled ...